Effient and Brilinta Equal for Post-MI Prevention

ACC Conference Reporter

ESC Congress 2016 | ROME — A head-to-head randomized showdown between prasugrel (Effient) and ticagrelor (Brilinta) turned up no difference in cardiovascular prevention after urgent revascularization, although in an underpowered trial. Read More >>>

Keywords: ESC Congress


< Back to Listings